Sandvik to divest Sandvik Medical Solutions

Sandvik to divest Sandvik Medical Solutions

Sandvik has reached an agreement with Orchid Orthopedic Solutions (Orchid),
owned by Altor Fund III, to divest Sandvik Medical Solutions, a unit within the
Sandvik Venture business area with contract manufacturing of medical implants
and instruments for orthopaedic and dental applications. In 2011 the operation
had sales of approximately 600 MSEK (90 MUSD) and comprised production units in
US and UK with about 550 employees.

“The divestment of Sandvik Medical Solutions is in line with our strategy to
exit operations outside of the defined core businesses. There is a strong
industrial logic in combining Orchid and Sandvik Medical Solutions and we are
convinced that Sandvik Medical Solutions will have a positive development with
its new owners”, says Anders Thelin, president of Sandvik Venture.

”The combination of Orchid and Sandvik Medical Solutions will have a unique
offering to its customers and become the leading orthopaedic implant supplier
globally. The acquisition also demonstrates Orchid’s commitment to be a leader
in a consolidating industry”, says Claes Ekström, Board Member in Orchid and
Partner at Altor Equity Partners.

The divestment is expected to be concluded in March 2012.

Sandviken, 24 February 2012

Sandvik Aktiebolag (publ)

Sandvik AB discloses the information provided herein pursuant to the Securities
Markets Act and/or the Financial Instruments Trading Act. The information was
submitted for publication at
09.00 CET on 24 February 2012.

For further information, contact Anders Thelin, President of Sandvik Venture
business area, tel: +46 26 26 63 84 or Jan Lissåker, Vice President Investor
Relations, SandvikAB,
tel: +46 26 26 10 23.